SCN5A (G892A) gene is associated with AV block conduction disorder in north Indian population
DOI:
https://doi.org/10.7439/ijbr.v7i1.2686Abstract
Objective- Electrical abnormalities of the heart cause the cardiac arrhythmia with or without essential structural heart disease. Due to genetic variation, cardiac arrhythmia can occur in any age group patients as well as in healthy people. The present study aimed to examine the allele and genotype of SCN5A (G892A) gene in cardiac conduction disorder (especially AV block conduction disorder) cases and comparison with healthy controls. Method- A total number of 104 cases and 104 controls were enrolled in this study. DNA was extracted using salting out method followed by polymerase chain reaction amplification and restriction endonuclease digestion (using AluI restriction enzyme). Digested PCR products were identified using agarose gel electrophoresis and stained with ethidium bromide. Results- There was a strong association of SCN5A G892A polymorphisms (GA vs. GG, OR= 4.01 and AA vs. GG OR= 3.12) with cardiac conduction disorder. Further multivariate logistic regression analysis, after adjustment for age, gender showed that when compared with wild type GG genotype, carriers of the A alleles had an increase risk of cardiac conduction disorder (OR-1.89, 95%CI- 0.78-1.67, p value- 0.0001). Conclusion- In conclusion the results of the present study suggest that the SCN5A G892A gene polymorphism carries an increased risk for cardiac conduction disorder in north Indian populations.Downloads
References
Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995;92(3):442
Balmer C, Fasnacht M, Rahn M, Molinari L, Bauersfeld U. Long-term follow up of children with congenital complete atrioventricular block and the impact of pacemaker therapy. Europace 2002 Oct;4(4):345-9.
Benson DW.Genetics of atrioventricular conduction disease in humans. Anat Rec A Discov Mol Cell Evol Biol 2004 Oct;280(2):934-9.
Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995 Mar10;80(5):805-11.
Bennett, P. B., Yazawa, K.,Naomasa, M., George, A. L. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995;376:683-5.
Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998 March19;392(6673):293-6.
Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999;23(1):20-1.
Tan HL, Bink-Boelkens MT, Bezzina CR, Viswanathan PC, Beaufort-Krol GC, van Tintelen PJ, et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 2001 Feb22;409(6823):1043-7.
George AL Jr., Varkony TA, Drabkin HA, Han J,Knops JF, Finley WH, et al. Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 3p21. Cytogenet Cell Genet 1995;68:67
Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996;34:9
Koopmann TT, Bezzina CR, Wilde AAM. Voltage-gated sodium channels: action players with many faces. Ann Med 2006;38:472
Zimmer T, Surber R. SCN5A channelopathies
Grant AO. Molecular biology of sodium channels and their role in cardiac arrhythmias. Am J Med 2001;110:296
Abriel H. Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology. J Mol Cell Cardiol 2010;48:2
Wang DW, Viswanathan PC, Balser JR, George AL Jr, Benson DW. Clinical, Genetic, and Biophysical Characterization of SCN5A Mutations Associated With Atrioventricular Conduction Block. Circulation.2002;105:341-346.
Park HS, Kim YN, Lee YS, Jung BC, Lee SH, Shin DG, et al. Genetic Analysis of SCN5A in Korean Patients Associated with Atrioventricular Conduction Block. Genomics Inform 2012 Jun;10(2):110-6. doi: 10.5808/GI.2012.10.2.110. Epub 2012 Jun 30.
McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University, National Center for Biotechnology Information, National Library of Medicine. Bethesda, MD: Online Mendelian Inheritance in Man, OMIM. Accessed 2001 Dec 5. Available from: http://www.ncbi.nlm.nih.gov/omim/.
Brink PA, Ferreira A, Moolman JC, Weymar HW, van der Merwe PL, Corfield VA. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 1995;91: 1633-40.
Jarvik ME. Beneficial effects of nicotine. Br J Addict 1991;86:571
Lakier JB. Smoking and cardiovascular disease. Am J Med 1992;93: 8S
Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29: 1422
Nowak R. Was safer cigarette research snuff? Science 1994;264: 766
Westman EC. Does smokeless tobacco cause hypertension? South Med J 1995;88:716
Chevalier H-J, Kuhnigk C, Bandilla R, Dontenwill W, Hiinel J. Effect of high doses of nicotine in pigs, L Changes of the electrocardiogram. Basic Res Cardio171, 68-75.
Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 1996;93:2033
Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993;119:1187
Stewart PM, Catterall JR. Chronic nicotine ingestion and atrial fibrillation. Br Heart J 1985;54:222
Benowitz NL. Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.